The Lincoln, Nebraska Journal Star (www.journalstar.com) ran an AP story on 3/23 announcing a $30 million state tax incentive package for a proposed $146 million plant expansion and creation of 287 new jobs at the BD Columbus plant. The next day, the stock dropped to $28 while the market rose. Makes no sense. The Columbus plant is the flagship mfg. plant for needles and some syringe sizes, and is the location where new products (i.e. safety products) are initially produced. I am a former employee, and a significant part of my retirement account is BD stock. Top management may have made some mistakes, but they have also done a lot to create the demand for the new safety products. Since BD owns the market for syringes and needles, this is the best area for domestic growth. They are clearly interested more in the long term health of the company than in short-term market manipulation. That's just fine with me.